![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_u2F4gM7LDFbzc8CUIG2Kny5m9-WZAjjp4761Bc38lE3OTP2OF9eJ2UYRvm4usREOMoxXo9eDGTxpF7jJILTxaDtMPi1eLax0rFmN6gfZU=s0-d){kind=small}
Public release date: 9-Mar-2012[ | E-mail |
Share ] Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Arizona Myeloma Network focuses conference on 'living' with cancer
SCOTTSDALE, Ariz. March 9, 2012 The Translational Genomics Research Institute (TGen) will present new research about the blood-cell cancer known as multiple myeloma at a free public conference hosted by the Arizona Myeloma Network (AzMN).
More than 300 people are expected at AzMN's 6th annual "Living with Myeloma" conference, planned from 8 a.m.-4:30 p.m. Saturday, March 24, at the Chaparral Suites Ballroom, 5001 N. Scottsdale Road, Scottsdale, Ariz.
The conference is designed to provide patients, their families, friends, caregivers, researchers, physicians and healthcare professionals with cutting-edge information about the latest research and the newest therapies for myeloma, which is a complex and often misdiagnosed cancer of bone marrow plasma cells that attacks and destroys bone.
TGen's Dr. Bodour Salhia, an Assistant Professor in TGen's Integrated Cancer Genomics Division, will present her research, looking into novel approaches for targeting multiple myeloma.
"It's exciting to be able to present at this conference," Dr. Salhia said. "Forums like the Living with Myeloma conference help to empower people living with myeloma to have knowledge and hope; two critical elements of recovery."
In addition to TGen's Dr. Salhia, other nationally recognized myeloma experts scheduled for the conference are: Dr. Robert Kyle and Dr. Joseph Mikhael of the Mayo Clinic, Dr. Bart Barlogie of the University of Arkansas, Dr. Cristina Gasparetto of Duke University, and Dr. Jeffrey Schriber of Scottsdale Healthcare's Virginia G. Piper Cancer Center and Arizona Oncology.
"Our myeloma conferences have become an important opportunity for patients and families to learn about this rare form of blood cancer, and other cancers, and feel less alone," says Barbara Kavanagh, Founder and President of the Arizona Myeloma Network.
Registration is available online at http://azmyelomanetwork.org/what/2012confreg.html, or from 8-9 a.m. at the conference. Free continental breakfast and lunch will be provided, and 5.5 Continuing Medical Education credits are available to medical professionals.
###
About the Arizona Myeloma Network
Founded in 2004, the Arizona Myeloma Network (AzMN) is a 501(c)(3) nonprofit charity organization that conducts outreach events and education programs, with special consideration for the underserved African-American, Asian-Pacific, Hispanic American and Native American populations. Volunteers and donations are always welcomed. For more information, visit: www.azmyelomanetwork.org.
Press Contact:
Barbara Kavanagh
623-388-6837
AzMyelomaNetwork@cox.net
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 9-Mar-2012[ | E-mail |
Share ] Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Arizona Myeloma Network focuses conference on 'living' with cancer
SCOTTSDALE, Ariz. March 9, 2012 The Translational Genomics Research Institute (TGen) will present new research about the blood-cell cancer known as multiple myeloma at a free public conference hosted by the Arizona Myeloma Network (AzMN).
More than 300 people are expected at AzMN's 6th annual "Living with Myeloma" conference, planned from 8 a.m.-4:30 p.m. Saturday, March 24, at the Chaparral Suites Ballroom, 5001 N. Scottsdale Road, Scottsdale, Ariz.
The conference is designed to provide patients, their families, friends, caregivers, researchers, physicians and healthcare professionals with cutting-edge information about the latest research and the newest therapies for myeloma, which is a complex and often misdiagnosed cancer of bone marrow plasma cells that attacks and destroys bone.
TGen's Dr. Bodour Salhia, an Assistant Professor in TGen's Integrated Cancer Genomics Division, will present her research, looking into novel approaches for targeting multiple myeloma.
"It's exciting to be able to present at this conference," Dr. Salhia said. "Forums like the Living with Myeloma conference help to empower people living with myeloma to have knowledge and hope; two critical elements of recovery."
In addition to TGen's Dr. Salhia, other nationally recognized myeloma experts scheduled for the conference are: Dr. Robert Kyle and Dr. Joseph Mikhael of the Mayo Clinic, Dr. Bart Barlogie of the University of Arkansas, Dr. Cristina Gasparetto of Duke University, and Dr. Jeffrey Schriber of Scottsdale Healthcare's Virginia G. Piper Cancer Center and Arizona Oncology.
"Our myeloma conferences have become an important opportunity for patients and families to learn about this rare form of blood cancer, and other cancers, and feel less alone," says Barbara Kavanagh, Founder and President of the Arizona Myeloma Network.
Registration is available online at http://azmyelomanetwork.org/what/2012confreg.html, or from 8-9 a.m. at the conference. Free continental breakfast and lunch will be provided, and 5.5 Continuing Medical Education credits are available to medical professionals.
###
About the Arizona Myeloma Network
Founded in 2004, the Arizona Myeloma Network (AzMN) is a 501(c)(3) nonprofit charity organization that conducts outreach events and education programs, with special consideration for the underserved African-American, Asian-Pacific, Hispanic American and Native American populations. Volunteers and donations are always welcomed. For more information, visit: www.azmyelomanetwork.org.
Press Contact:
Barbara Kavanagh
623-388-6837
AzMyelomaNetwork@cox.net
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2012-03/ttgr-trp030812.php
gas prices rising stars challenge jeb bush star trek 2 kathy ireland dharun ravi brooke mueller
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.